Condition
HER2 Positive Solid Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 2 HER2 Positive Solid Tumor clinical trials that are recruiting, at sites in 4 countries (most in Netherlands (1), Australia (1), South Korea (1)). By phase: Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
TGW211 click-cleavable imaging for HER2-positive cancers
This trial tries TGW211, a trastuzumab-based agent with a click-cleavable tag, to see if it gives clearer SPECT scans for adults with HER2-positive cancers.
-
Treatment with YH32367 for HER2 Positive Advanced Solid Tumors
This study is testing a new treatment called YH32367 to see if it can safely help people with advanced solid tumors that are HER2-positive.
Quick answers
How many HER2 Positive Solid Tumor clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Netherlands (1 trial), Australia (1 trial), South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.